FERMENTA BIOTECH Financial Statement Analysis
|
||
|
The Revenues of FERMENTA BIOTECH have increased by 11.92% YoY .
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by -5.01 % YoY. |
||
FERMENTA BIOTECH Last 5 Annual Financial Results
[BOM: 506414|NSE : FERMENTA]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹525 Cr | ₹469 Cr | ₹336 Cr | ₹350 Cr | ₹399 Cr |
| Expenses | ₹424 Cr | ₹359 Cr | ₹308 Cr | ₹332 Cr | ₹336 Cr |
| Operating Profit (Excl OI) | ₹101 Cr | ₹111 Cr | ₹28 Cr | ₹18 Cr | ₹62 Cr |
| Other Income | ₹22 Cr | ₹12 Cr | ₹12 Cr | ₹8.60 Cr | ₹8.25 Cr |
| Interest | ₹13 Cr | ₹15 Cr | ₹17 Cr | ₹21 Cr | ₹18 Cr |
| Depreciation | ₹22 Cr | ₹24 Cr | ₹25 Cr | ₹28 Cr | ₹26 Cr |
| Profit Before Tax | ₹96 Cr | ₹83 Cr | ₹-9.87 Cr | ₹-51 Cr | ₹27 Cr |
| Profit After Tax | ₹70 Cr | ₹76 Cr | ₹-24 Cr | ₹-53 Cr | ₹15 Cr |
| Consolidated Net Profit | ₹72 Cr | ₹77 Cr | ₹-23 Cr | ₹-51 Cr | ₹15 Cr |
| Earnings Per Share (Rs) | ₹25.03 | ₹26.35 | ₹-7.99 | ₹-17.70 | ₹5.35 |
| PAT Margin (%) | 13.37 | 16.27 | -7.15 | -15.18 | 3.78 |
| ROE(%) | 18.36 | 23.93 | -8.30 | -16.11 | 4.27 |
| ROCE(%) | 21.99 | 21.97 | 1.58 | -5.25 | 7.50 |
| Total Debt/Equity(x) | 0.27 | 0.30 | 0.48 | 0.72 | 0.66 |
Key Financials |
||
| Market Cap | : | ₹ 1,499.4 Cr |
| Revenue (TTM) | : | ₹ 511.0 Cr |
| Net Profit(TTM) | : | ₹ 58.2 Cr |
| EPS (TTM) | : | ₹ 19.8 |
| P/E (TTM) | : | 25.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FERMENTA BIOTECH | 7.4% | 9.6% | 44.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -4% | 15.7% |
| DIVIS LABORATORIES | 9.1% | 18.2% | 47.1% |
| TORRENT PHARMACEUTICALS | 3.6% | 3.4% | 36.4% |
| CIPLA | -1.2% | -3.3% | -10.8% |
| DR REDDYS LABORATORIES | -1.4% | 2.9% | -8% |
| MANKIND PHARMA | 0.5% | -7.4% | -7.3% |
| LUPIN | -0.7% | -10.1% | 9.6% |
| ZYDUS LIFESCIENCES | 7.8% | 6.4% | 20.3% |
FERMENTA BIOTECH Revenues
[BOM: 506414|NSE : FERMENTA]
| Y-o-Y | 11.92 % |
| 5 Yr CAGR | 7.16 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹525 Cr | 11.92 | |
| Mar2025 | ₹469 Cr | 39.87 | |
| Mar2024 | ₹336 Cr | -4.08 | |
| Mar2023 | ₹350 Cr | -12.19 | |
| Mar2022 | ₹399 Cr | - | |
FERMENTA BIOTECH Operating Profit
[BOM: 506414|NSE : FERMENTA]
| Y-o-Y | -8.64 % |
| 5 Yr CAGR | 12.86 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹101 Cr | -8.64 | |
| Mar2025 | ₹111 Cr | 296.20 | |
| Mar2024 | ₹28 Cr | 53.28 | |
| Mar2023 | ₹18 Cr | -70.76 | |
| Mar2022 | ₹62 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -18.39 % |
| 5 Yr CAGR | 5.31 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 19.21% | -18.39 | |
| Mar2025 | 23.54% | 183.27 | |
| Mar2024 | 8.31% | 59.81 | |
| Mar2023 | 5.2% | -66.71 | |
| Mar2022 | 15.62% | - | |
FERMENTA BIOTECH Profit After Tax
[BOM: 506414|NSE : FERMENTA]
| Y-o-Y | -6.63 % |
| 5 Yr CAGR | 46.81 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹72 Cr | -6.63 | |
| Mar2025 | ₹77 Cr | Positive | |
| Mar2024 | ₹-23 Cr | Negative | |
| Mar2023 | ₹-51 Cr | Negative | |
| Mar2022 | ₹15 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -17.82 % |
| 5 Yr CAGR | 37.14 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 13.37 % | -17.82 | |
| Mar2025 | 16.27 % | Positive | |
| Mar2024 | -7.15 % | Negative | |
| Mar2023 | -15.18 % | Negative | |
| Mar2022 | 3.78 % | - | |
FERMENTA BIOTECH Earnings Per Share (EPS)
[BOM: 506414|NSE : FERMENTA]
| Y-o-Y | -5.01 % |
| 5 Yr CAGR | 47.07 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹25 | -5.01 | |
| Mar2025 | ₹26 | Positive | |
| Mar2024 | ₹-7.99 | Negative | |
| Mar2023 | ₹-18 | Negative | |
| Mar2022 | ₹5.35 | - | |
FERMENTA BIOTECH Return on Capital Employed (ROCE)
[BOM: 506414|NSE : FERMENTA]
| Y-o-Y | 0.09 % |
| 5 Yr CAGR | 30.86 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 21.99% | 0.09 | |
| Mar2025 | 21.97% | 1,290.51 | |
| Mar2024 | 1.58% | Positive | |
| Mar2023 | -5.25% | Negative | |
| Mar2022 | 7.5% | - | |
FERMENTA BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹510.0 |
| Current MarketCap | : | ₹ 1,499.4 Cr |
| Updated EOD on | : | Aug 28,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | 7.4% |
9.6% |
44.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
FERMENTA BIOTECH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 2.1% | 1.6% | 15.3% |
No NSE index found
You may also like the below Video Courses
FAQ about FERMENTA BIOTECH Financials
How the annual revenues of FERMENTA BIOTECH have changed ?
The Revenues of FERMENTA BIOTECH have increased by 11.92% YoY .
How the Earnings per Share (EPS) of FERMENTA BIOTECH have changed?
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by -5.01 % YoY .
Check out Intrinsic Value of Peers of FERMENTA BIOTECH
Compare Stock Analytics of Peers of FERMENTA BIOTECH
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
